Due to its involvement in CNS water homeostasis, AQP4 has emerged as a potential drug target in neurodegenerative diseases and CNS edema [111,112], and it was recently demonstrated that targeting AQP4 subcellular relocalization in astrocytes is a viable strategy for CNS edema following traumatic injury [111]. This evidence concerns the gene AQP4 and neurodegenerative disease.